Skip to main content

Advertisement

Table 2 Distribution of patients according to the dose of fotemustine received

From: Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Group Induction dose, mg/m2 (no. pts) Maintenance dose, mg/m2 (no. of pts) All pts no. = 40
A 65 (5) 75 (5) 5
B 75 (15) 75 (10) – 85 (5) 15
C 85 (10) – 100 (10) 75/85 (18) – 100 (2) 20
  1. no., number; pts, patients